Q2M Biotech AG (HAM:QBI) Accounts Receivable : €0.00 Mil (As of . 20)

View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Q2M Biotech AG's accounts receivables for the quarter that ended in . 20 was €0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Q2M Biotech AG's Net-Net Working Capital per share for the quarter that ended in . 20 was €N/A.

Q2M Biotech AG Accounts Receivable Historical Data

The historical data trend for Q2M Biotech AG's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Accounts Receivable Chart

Q2M Biotech AG Annual Data

Trend

Accounts Receivable

Q2M Biotech AG Quarterly Data

Accounts Receivable

Q2M Biotech AG Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Q2M Biotech AG Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Q2M Biotech AG's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=		/		*	91
=

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Q2M Biotech AG's accounts receivable are only considered to be worth 75% of book value:

Q2M Biotech AG's Net-Net Working Capital Per Share for the quarter that ended in . 20 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(	+	0.75 *	+	0.5 *	-	N/A
-		-	)	/	0
=	N/A

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Q2M Biotech AG Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Q2M Biotech AG (HAM:QBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Haeschenstrasse 17-19, Bremen, DEU

Website

http://

Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines